Results 181 to 190 of about 2,290 (211)
Some of the next articles are maybe not open access.

Dipeptidyl Peptidase-4 – A Comprehensive Review

Current Enzyme Inhibition
Type 2 diabetes mellitus is a growing global public health issue, with its prevalence projected to increase in the coming decades. It is one of the most prevalent and growing global health concerns, affecting millions of individuals worldwide. The condition is classified into two primary types: Type 1 diabetes,
Venkatesan Parthasarathi   +1 more
openaire   +1 more source

Dipeptidyl Peptidase-4 Inhibitors

2014
Ranjit Unnikrishnan   +2 more
openaire   +1 more source

Inhibitors of Dipeptidyl Peptidase 4

2005
Stephen L. Gwaltney, Jeffrey A. Stafford
openaire   +1 more source

Dipeptidyl peptidase-4 (DPP-4)

Science-Business eXchange, 2012
openaire   +1 more source

Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors

Bioorganic and Medicinal Chemistry Letters, 2006
John Pedersen
exaly  

A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells

Journal of Experimental Medicine, 1999
Alan N Houghton   +2 more
exaly  

Dipeptidyl Peptidase-4 in Cariometabolic Disease

The cardiovascular implications of modulating cell specific expression of the serine protease dipeptidyl peptidase-4 (DPP4) were investigated in a series of murine models of metabolic dysfunction-associated steatotic liver disease (MASLD), cardiometabolic disease and myocardial infarction. In vivo experiments were conducted using several genetic models,
openaire   +1 more source

Home - About - Disclaimer - Privacy